The Expression and Clinical Significance of Sphingosine Kinase 1 and Vascular Endothelial Growth Factor in Endometrial Carcinoma

The Expression and Clinical Significance of Sphingosine Kinase 1 and Vascular Endothelial Growth Factor in Endometrial Carcinoma

The aim of the study is to investigate the expression of sphingosine kinase 1 (SPHK1) and vascular endothelial growth factor (VEGF) in patients with endometrial carcinoma and its clinical significance. The tissues of 86 cases of patients with endometrial carcinoma and 54 cases of patients with endom...

Full description

Bibliographic Details
Main Authors:	Hong Yu, null Dejizhuoga, Wei Huang, Donglian Wang, null Gamaquzhen, Xiaomin Jia, Hao Feng
Format:	Article
Language:	English
Published:	Hindawi Limited 2022-01-01
Series:	Emergency Medicine International
Online Access:	http://dx.doi.org/10.1155/2022/6716143

Similar Items

Retracted: The Expression and Clinical Significance of Sphingosine Kinase 1 and Vascular Endothelial Growth Factor in Endometrial Carcinoma
by: Emergency Medicine International
Published: (2024-01-01)

The Impact of Sphingosine Kinases on Inflammation-Induced Cytokine Release and Vascular Endothelial Barrier Integrity
by: Andreas V. Thuy, et al.
Published: (2022-10-01)

Endometrial carcinoma: Angiogenesis and review of the role of vascular endothelial growth factor
by: Obradović Danilo, et al.
Published: (2022-01-01)

Regulation of S1P receptors and sphingosine kinases expression in acute pulmonary endothelial cell injury
by: Huiying Liu, et al.
Published: (2016-12-01)

Significance of CD47 expression in endometrial carcinoma
by: Nurhan Sahin, et al.
Published: (2022-01-01)

Transcriptional Regulation of Sphingosine Kinase 1
by: Joseph Bonica, et al.
Published: (2020-11-01)

Association study of vascular endothelial growth factor gene polymorphisms in endometrial carcinomas in a Japanese population.
by: Amano, M, et al.
Published: (2008)

Vascular endothelial growth factor expression in renal cell carcinoma
by: Mohtarrudin, Norhafizah, et al.
Published: (2018)

Expression of STAT3 in endometrial carcinoma and its clinicopathological significance
by: SUN Xinzhao, LUO Yanlu, FAN Jiangtao, ZHONG Xueyan
Published: (2023-10-01)

Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
by: Preeti Gupta, et al.
Published: (2021-04-01)

Sphingosine-1-Phosphate Receptor 3 Induces Endothelial Barrier Loss via ADAM10-Mediated Vascular Endothelial-Cadherin Cleavage
by: Jialin Wu, et al.
Published: (2023-11-01)

Crystal Structure of Sphingosine Kinase 1 with PF-543.
by: Wang, J, et al.
Published: (2014)

Sphingosine kinase 1 in murine dorsal root ganglia
by: Dimitra Beroukas, et al.
Published: (2015-02-01)

The Impact of Sphingosine Kinase-1 in Head and Neck Cancer
by: Toshihiko Kawamori, et al.
Published: (2013-08-01)

Sphingosine kinase/sphingosine 1-phosphate axis: a new player for insulin-like growth factor-1-induced myoblast differentiation
by: Bernacchioni Caterina, et al.
Published: (2012-07-01)

Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma
by: Beata Franczyk, et al.
Published: (2023-01-01)

Therapeutic potential of the sphingosine kinase 1 inhibitor, PF-543
by: Xueliang Yi, et al.
Published: (2023-07-01)

Sphingosine kinase 1/S1P receptor signaling axis is essential for cellular uptake of Neisseria meningitidis in brain endothelial cells.
by: Ingo Fohmann, et al.
Published: (2023-11-01)

The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target
by: Xianwang Wang PhD, et al.
Published: (2020-12-01)

Correction: Targeting Sphingosine Kinase 1 in Carcinoma Cells Decreases Proliferation and Survival by Compromising PKC Activity and Cytokinesis
Published: (2013-01-01)

Is Sphingosine-1-Phosphate a Regulator of Tumor Vascular Functionality?
by: Manale Karam, et al.
Published: (2022-03-01)

Sphingosine Kinases are Involved in Macrophage NLRP3 Inflammasome Transcriptional Induction
by: Shahzad Nawaz Syed, et al.
Published: (2020-07-01)

A Novel Sphingosine Kinase Inhibitor Suppresses Chikungunya Virus Infection
by: Opeoluwa O. Oyewole, et al.
Published: (2022-05-01)

Reduction of Sphingosine Kinase 1 Phosphorylation and Activity in Plasmodium-Infected Erythrocytes
by: Raj Kumar Sah, et al.
Published: (2020-03-01)

Microsatellite Instability and Its Clinical Significance in Endometrial Carcinoma
by: XIAO Jing, WU Ying
Published: (2022-01-01)

Assessment of the Effects of Sphingosine Kinase 1/Sphingosine-1-Phosphate on Microangiogenesis at Rat Myofascial Trigger Points Using Contrast-Enhanced Ultrasonography
by: Fang X, et al.
Published: (2024-02-01)

Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods
by: Li Gao, et al.
Published: (2022-05-01)

Ablation of sphingosine kinase 2 suppresses fatty liver-associated hepatocellular carcinoma via downregulation of ceramide transfer protein
by: Xin Tracy Liu, et al.
Published: (2022-11-01)

Role of sphingosine kinase in the expression of adhesion molecules on monocytes induced by tumor necrosis factor-alpha : relevance to atherosclerosis
by: Tuang, Chew Yan.
Published: (2008)

Characterization of Salmonella typhimurium YegS, a putative lipid kinase homologous to eukaryotic sphingosine and diacylglycerol kinases.
by: Nichols, C, et al.
Published: (2007)

Feline mammary carcinoma-derived extracellular vesicle promotes liver metastasis via sphingosine kinase-1-mediated premetastatic niche formation
by: Yi-Chih Chang, et al.
Published: (2023-11-01)

Targeting vascular endothelial growth factor in renal cell carcinoma.
by: Patel, N, et al.
Published: (2009)

Vascular endothelial growth factor expression in lung cancer.
by: O'Byrne, K, et al.
Published: (1998)

Expression of Vascular Endothelial Growth Factor in Uveal Melanoma
by: V. G. Likhvantseva, et al.
Published: (2021-12-01)

Correlation between Endometrial Vascular Endothelial Growth Factor Expression and Pregnancy Outcome of Frozen–Thawed Embryo Transfer in Patients with Repeated Implantation Failure
by: Rui Jin, et al.
Published: (2022-01-01)

Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity
by: Su Bin Kim, et al.
Published: (2020-05-01)

UCHL1 Regulates Radiation Lung Injury via Sphingosine Kinase-1
by: Yulia Epshtein, et al.
Published: (2023-10-01)

Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters
by: Anne Gomez-Brouchet, et al.
Published: (2022-01-01)

Determining the Anticancer Activity of Sphingosine Kinase Inhibitors Containing Heteroatoms in Their Tail Structure
by: Jitendra Shrestha, et al.
Published: (2022-01-01)

The anti-osteosarcoma cell activity by the sphingosine kinase 1 inhibitor SKI-V
by: Xu Sun, et al.
Published: (2022-02-01)